Barrientos, J., Doubek, M., Lazar, Z., Visentin, A., Serna, J. D. L., Laurenti, L., Sanna, A., Rejto, L., Segundo, L. Y. S., Sportoletti, P., Gray, C., Bremer, C., Ouerdani, A., Treijtel, N., Hodkinson, B., Loffredo, J., Kavanagh, C., Srikanthan, S., Xu, P., Franceschini, E., Abbazio, C., Patterson, B., Messahel, B., Khan, W., Burger, J., Parisi, L., Wildgust, M., Ghia, P., Sharman, J. (2025). Dose and BTK occupancy relationship in the prospective Phase 2 TAILOR study: Exploratory end point analysis of the ibrutinib monotherapy cohorts in patients with previously untreated chronic lymphocytic leukemia. Blood. https://doi.org/10.1182/blood-2025-3301